Here are five points:
1. During Q3, the firm sold 250,000 AmSurg shares.
2. AmSurg comprises nearly 4.1 percent of Stonerise Capital Management’s portfolio.
3. As of it most recent filing with the U.S. Securities and Exchange Commission, Stonerise Capital Management owned 0.13 percent of AmSurg.
4. On Feb. 8, 2017, AmSurg shares increased 0.7 percent, reaching $69.02.
5. AmSurg’s market cap totals $3.71 billion.
More articles on surgery centers:
12 thoughts for surgery centers – 2017
Analysts give SCA shares ‘hold’ rating — 4 notes
BelHealth Investment Partners acquires American HealthCare Staffing Association — 5 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.